Pharmaceutical Technology

JULY 24, 2025

EU’s Pharma Package falls short of Europe’s goal of global competitiveness Why can’t the US figure out weight loss drug prices? July 24, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The companies aim to gain insights that could contribute information towards designing more vaccines.

Vaccines 52

Vaccines Packaging Communication Immunization 52

Pharmaceutical Technology

JULY 1, 2025

How will RFK Jr’s American dream for vaccines play out? The US Food and Drug Administration (FDA) has approved Takeda’s new immunoglobulin (IG) therapy, Gammagard liquid ERC [immune globulin infusion (human)], to treat primary immunodeficiency (PI) in individuals aged two years and above. Credit: HenadziPechan/Shutterstock.

Packaging 52

Packaging Communication Hospitals Drug Pricing 52

Pharmaceutical Technology

JULY 23, 2025

EU’s Pharma Package falls short of Europe’s goal of global competitiveness Why can’t the US figure out weight loss drug prices? July 23, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The acquisition includes vaccine candidates for respiratory syncytial virus and human metapneumovirus.

Health and Personal Care Stores 52

Health and Personal Care Stores Vaccines Packaging Communication 52

BioPharma Dive

JULY 16, 2025

Sarepta is working on a new regimen of immune-suppressing drugs to manage the safety risks, and plans to soon share its findings with the FDA. The company’s share price is lower by more than 80% this year amid concerns about Elevidys’ future and the chance new FDA leadership might restrict its use. TechTarget, Inc.s

Drug Pricing 121

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies Labelling 121

Pharmaceutical Technology

JULY 3, 2025

How will RFK Jr’s American dream for vaccines play out? By GlobalData Learn more about Strategic Intelligence Boxed warnings are common for T-cell directing drugs, and Lynozyfic is no different.

Packaging 52

Packaging Communication Hospitals Drug Pricing 52

Pharmaceutical Technology

JULY 1, 2025

How will RFK Jr’s American dream for vaccines play out? A preliminary look at the data from Capstan has revealed strong B-cell depletion – the aim of the treatment is to achieve an ‘immune reset’ by repopulation of healthy B cells. Investors shared positive sentiment in the acquisition, with shares in NYSE-listed AbbVie closing 1.7%

Insurance Coverage and Processing 52

Insurance Coverage and Processing Packaging Communication Hospitals 52

Pharmaceutical Technology

JULY 14, 2025

How will RFK Jr’s American dream for vaccines play out? Sectors Sections Clinical Trials Drug Manufacturers Therapy Area Pricing and Market Access Latest EC approves BeOne’s Tevimbra for nasopharyngeal carcinoma Formulate Faster. MAXSHOT.PL via Shutterstock. A decision by the FDA is expected in H1 2026.

Labelling 52

Labelling Vaccines Insurance Coverage and Processing Packaging 52

Pharmaceutical Technology

JULY 8, 2025

How will RFK Jr’s American dream for vaccines play out? Go deeper with GlobalData Reports LOA and PTSR Model - Briquilimab in Severe Combined Immune Deficien. Reports LOA and PTSR Model - Immune Globulin (Human) in Chronic Lymphocytic. Reports LOA and PTSR Model - Immune Globulin (Human) in Chronic Lymphocytic.

Immunization 52

Immunization Immunity Packaging Hospitals 52

Pharmaceutical Technology

JULY 15, 2025

How will RFK Jr’s American dream for vaccines play out? The share price in the company had climbed 3.6% LaNova’s drug development focuses on tumour immunity and the tumour microenvironment. The company has particular emphasis on antibody-drug conjugates (ADCs) and has built several platforms within this modality.

Packaging 75

Packaging Communication Hospitals Drug Development 75

Pharmaceutical Technology

JULY 11, 2025

How will RFK Jr’s American dream for vaccines play out? Its design minimises interaction with Fc-gamma (Fcγ) receptors on macrophages, enhancing the ability of the body’s immune cells to recognise and combat tumours.

Packaging 52

Packaging Hospitals Biosimilars Communication 52

Pharmaceutical Technology

JULY 4, 2025

How will RFK Jr’s American dream for vaccines play out? Go deeper with GlobalData Reports LOA and PTSR Model - Briquilimab in Severe Combined Immune Deficien. Nominate Now Share Copy Link Share on X Share on Linkedin Share on Facebook Go deeper with GlobalData Reports LOA and PTSR Model - Briquilimab in Severe Combined Immune Deficien.

Hospitals 52

Hospitals Packaging Communication Immunization 52

BioPharma Dive

JUNE 11, 2025

billion buyout of Blueprint Medicines is the sector’s second-largest M&A deal this year and represents the highest value paid for an immune drug developer since April 2023. You can unsubscribe at anytime. Track the deals that are happening here. Sanofi’s $9.1 Track the deals that are happening here. Sanofi’s $9.1

Drug Pricing 108

Drug Pricing Immunization Immunity Drug Development 108

Pharmaceutical Technology

JULY 15, 2025

How will RFK Jr’s American dream for vaccines play out? LEO’s new asset is a monoclonal antibody that blocks the activation of the interleukin-36 (IL-36) receptor – a key signalling pathway in the immune system implicated in the pathogenesis of several autoinflammatory diseases.

Packaging 52

Packaging Communication Hospitals Vaccines 52

Pharmaceutical Technology

JUNE 10, 2025

Robert Barrie and Ross Law June 10, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The removal ACIP members marks the most significant upheaval to the current vaccine landscape under Trump’s administration. Go deeper with GlobalData Reports United States of America (USA) Drug Pricing and Reimbursement Lands.

Vaccines 52

Vaccines Insurance Coverage and Processing Drug Pricing Immunization 52

BioPharma Dive

JULY 18, 2025

After the second death, Sarepta began working on a new regimen of immune-suppressing drugs it hopes will make treatment safer. You can unsubscribe at anytime. Treating muscular dystrophies can require large doses, which is thought to raise the chances of dangerous liver side effects. Registered in England and Wales. TechTarget, Inc.s

Drug Pricing 63

Drug Pricing Vaccines Immunization Immunity 63

BioPharma Dive

JULY 22, 2025

Deep Dive Library Events Press Releases Topics Sign up Search Sign up Search Pharma Biotech FDA Clinical Trials Deals Drug Pricing Gene Therapy An article from Dive Brief // Vaccines Sanofi to acquire vaccine biotech in billion-dollar deal The French pharma will pay $1.15 headquarters in Bridgewater, New Jersey.

Vaccines 57

Vaccines Drug Pricing Labelling Biosimilars 57

NY Times

MARCH 24, 2021

The pharmaceutical industry doesn’t want things to change, but Americans can have both lower prices and innovation.

Drug Pricing 98

Drug Pricing Immunity Immunization Vaccines 98

BioPharma Dive

JULY 23, 2025

Dispatch aims to deliver to cancer cells a sequence for a unique type of protein flag, known as an antigen, that it says can draw in specially engineered immune cells it plans to administer afterwards. Drugs like Merck & Co.’s s Keytruda, known as checkpoint inhibitors, can spur the immune system to fight cancer.

Specialty Pharmacies 118

Specialty Pharmacies Immunization Immunity Drug Pricing 118

STAT

OCTOBER 8, 2024

The trade group, however, insisted the FDA “acted to benefit special interests, raise drug prices and deprive much of the public of access to a needed medicine.” A group of doctors and medical practices claimed they overpaid for the vaccine, which was the only mumps shot in the U.S. ” A U.S.

Compounding 258

Compounding Compounding Pharmacies Vaccines Immunization 258

pharmaphorum

JANUARY 13, 2023

These therapies have incredible potential to fight cancer and other diseases using the patient’s own immune system. Some will simply raise drug prices to get more money out of new drugs while they can; others are planning to phase in new indications in order to “reset the clock” as many times as they can.

Drug Pricing 98

Drug Pricing Immunization Immunity Vaccines 98

STAT

JUNE 12, 2025

’s handpicked members of a vaccine advisory committee, see Sen. Bill Cassidy quietly explore a “most-favored nation” pricing policy for prescription drugs, and more. installs vaccine critics on CDC panel Health secretary Robert F. Today, we look at health secretary RFK Jr.’s   RFK Jr.

Vaccines 159

Vaccines Drug Development Immunity Immunization 159

pharmaphorum

AUGUST 27, 2020

Regulatory pressures, lengthy drug development times, and the fact that drug prices have become politicised have raised risks and cut revenue projections, leading to the biotech sector falling out of fashion. Moreover, the range of companies benefiting from investor interest has not been limited to those developing a vaccine.

Vaccines 122

Vaccines Drug Pricing Compounding Pharmaceutical Companies 122

FDA Law Blog: Biosimilars

JUNE 2, 2023

Absent from the statute is any requirement to report information on manufacturer costs and price setting. Nevertheless, riding on the wave of drug price transparency legislation in several states and similar legislative proposals in Congress, CMS is proposing to expand the MDRP into the realm of drug price transparency reporting.

Labelling 59

Labelling Vaccines Drug Pricing Immunization 59

BioPharma Dive

JULY 23, 2025

Deep Dive Library Events Press Releases Topics Sign up Search Sign up Search Pharma Biotech FDA Clinical Trials Deals Drug Pricing Gene Therapy An article from Vaccines RFK Jr. In a statement, HHS said Kennedy’s action fulfills “a commitment to restore trust with Americans by removing risk while sustaining access to vaccines.”

Vaccines 46

Vaccines Drug Pricing Labelling Immunization 46

Pharmaceutical Technology

JULY 8, 2025

How will RFK Jr’s American dream for vaccines play out? Robert Barrie July 8, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The lawsuit marks the first legal challenge posited to RFK Jr and the HHS since his remodelling of vaccine regulation in the US.

Vaccines 75

Vaccines Packaging Communication Hospitals 75

BioPharma Dive

JUNE 23, 2025

Cidara will provide detailed results at a future medical meeting and intends to meet with the Food and Drug Administration to discuss the design of a Phase 3 trial. Study success could open the door to an alternative to seasonal influenza vaccines, which some Wall Street analysts view as a multibillion-dollar sales opportunity.

Vaccines 105

Vaccines Drug Pricing Immunization Immunity 105

STAT

JUNE 13, 2025

See you soon… The Trump administration is pushing pharmaceutical companies to begin negotiations to bring their drug prices in line with what other countries pay — usually far less than Americans , STAT tells us.   Two new vaccine advisers tapped by U.S. Health and Human Services Secretary Robert F.

Vaccines 159

Vaccines Pharmaceutical Companies Pharmaceutical Companies Drug Pricing 159

Safe Biologics

MARCH 10, 2025

This expansion continues a flawed policy that threatens innovation and jeopardizes patient access to critical treatments, including drugs vital for cancer treatment and popular new weight loss medications that have transformed the management of obesity and related conditions. What Will 2025 Mean for Medicare Drug Price Setting Under the IRA?

Biosimilars 130

Biosimilars Independent Pharmacies Drug Pricing Vaccines 130

STAT

NOVEMBER 8, 2024

have on vaccines in the U.S.? ’s vaccine views could shape policy President-elect Trump’s decision to entrust noted vaccine skeptic Robert F. One of particular import: What impact will his relationship with Robert F. Kennedy Jr. We have a look at that question today, discuss another U.S. How RFK Jr.’s

Vaccines 272

Vaccines Immunity Immunization Drug Pricing 272